Global Over the Counter (OTC) & Diet Supplementary Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 92
Inquire Before Buying

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease.

Highlights

The global Over the Counter (OTC) & Diet Supplementary market was valued at US$ 135920 million in 2022 and is anticipated to reach US$ 207730 million by 2029, witnessing a CAGR of 5.8% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Over the Counter (OTC) & Diet Supplementary is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Over the Counter (OTC) & Diet Supplementary is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Over the Counter (OTC) & Diet Supplementary include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) & Diet Supplementary, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) & Diet Supplementary.

The Over the Counter (OTC) & Diet Supplementary market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Over the Counter (OTC) & Diet Supplementary market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Over the Counter (OTC) & Diet Supplementary manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Bayer AG

- Merck KGaA

- Novartis

- Johnson & Johnson

- GlaxoSmithKline

- Alkem Laboratories

- Teva Pharmaceutical Industries

- Pfizer

- Sun Pharma

- Allergan

Segment by Type

- Analgesic & Pain Relievers

- Dermatological Products

- Cough, Cold and Flu Products

- Vitamin Supplements

- Mineral Supplements

- Ophthalmic Products

Segment by Application

- Hospital

- Clinic

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Over the Counter (OTC) & Diet Supplementary manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Over the Counter (OTC) & Diet Supplementary in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Over the Counter (OTC) & Diet Supplementary Market Research Report 2023

Table of Contents
1 Over the Counter (OTC) & Diet Supplementary Market Overview
1.1 Product Overview and Scope of Over the Counter (OTC) & Diet Supplementary
1.2 Over the Counter (OTC) & Diet Supplementary Segment by Type
1.2.1 Global Over the Counter (OTC) & Diet Supplementary Market Value Comparison by Type (2023-2029)
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Over the Counter (OTC) & Diet Supplementary Segment by Application
1.3.1 Global Over the Counter (OTC) & Diet Supplementary Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Over the Counter (OTC) & Diet Supplementary Market Size Estimates and Forecasts
1.4.1 Global Over the Counter (OTC) & Diet Supplementary Revenue 2018-2029
1.4.2 Global Over the Counter (OTC) & Diet Supplementary Sales 2018-2029
1.4.3 Global Over the Counter (OTC) & Diet Supplementary Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Over the Counter (OTC) & Diet Supplementary Market Competition by Manufacturers
2.1 Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Manufacturers (2018-2023)
2.2 Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Over the Counter (OTC) & Diet Supplementary Average Price by Manufacturers (2018-2023)
2.4 Global Over the Counter (OTC) & Diet Supplementary Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Over the Counter (OTC) & Diet Supplementary, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Over the Counter (OTC) & Diet Supplementary, Product Type & Application
2.7 Over the Counter (OTC) & Diet Supplementary Market Competitive Situation and Trends
2.7.1 Over the Counter (OTC) & Diet Supplementary Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Over the Counter (OTC) & Diet Supplementary Players Market Share by Revenue
2.7.3 Global Over the Counter (OTC) & Diet Supplementary Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Over the Counter (OTC) & Diet Supplementary Retrospective Market Scenario by Region
3.1 Global Over the Counter (OTC) & Diet Supplementary Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Over the Counter (OTC) & Diet Supplementary Global Over the Counter (OTC) & Diet Supplementary Sales by Region: 2018-2029
3.2.1 Global Over the Counter (OTC) & Diet Supplementary Sales by Region: 2018-2023
3.2.2 Global Over the Counter (OTC) & Diet Supplementary Sales by Region: 2024-2029
3.3 Global Over the Counter (OTC) & Diet Supplementary Global Over the Counter (OTC) & Diet Supplementary Revenue by Region: 2018-2029
3.3.1 Global Over the Counter (OTC) & Diet Supplementary Revenue by Region: 2018-2023
3.3.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Region: 2024-2029
3.4 North America Over the Counter (OTC) & Diet Supplementary Market Facts & Figures by Country
3.4.1 North America Over the Counter (OTC) & Diet Supplementary Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2029)
3.4.3 North America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Over the Counter (OTC) & Diet Supplementary Market Facts & Figures by Country
3.5.1 Europe Over the Counter (OTC) & Diet Supplementary Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2029)
3.5.3 Europe Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Over the Counter (OTC) & Diet Supplementary Market Facts & Figures by Country
3.6.1 Asia Pacific Over the Counter (OTC) & Diet Supplementary Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2029)
3.6.3 Asia Pacific Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Over the Counter (OTC) & Diet Supplementary Market Facts & Figures by Country
3.7.1 Latin America Over the Counter (OTC) & Diet Supplementary Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2029)
3.7.3 Latin America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Over the Counter (OTC) & Diet Supplementary Market Facts & Figures by Country
3.8.1 Middle East and Africa Over the Counter (OTC) & Diet Supplementary Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2029)
3.8.3 Middle East and Africa Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Over the Counter (OTC) & Diet Supplementary Sales by Type (2018-2029)
4.1.1 Global Over the Counter (OTC) & Diet Supplementary Sales by Type (2018-2023)
4.1.2 Global Over the Counter (OTC) & Diet Supplementary Sales by Type (2024-2029)
4.1.3 Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Type (2018-2029)
4.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Type (2018-2029)
4.2.1 Global Over the Counter (OTC) & Diet Supplementary Revenue by Type (2018-2023)
4.2.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Type (2024-2029)
4.2.3 Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Type (2018-2029)
4.3 Global Over the Counter (OTC) & Diet Supplementary Price by Type (2018-2029)
5 Segment by Application
5.1 Global Over the Counter (OTC) & Diet Supplementary Sales by Application (2018-2029)
5.1.1 Global Over the Counter (OTC) & Diet Supplementary Sales by Application (2018-2023)
5.1.2 Global Over the Counter (OTC) & Diet Supplementary Sales by Application (2024-2029)
5.1.3 Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Application (2018-2029)
5.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Application (2018-2029)
5.2.1 Global Over the Counter (OTC) & Diet Supplementary Revenue by Application (2018-2023)
5.2.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Application (2024-2029)
5.2.3 Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Application (2018-2029)
5.3 Global Over the Counter (OTC) & Diet Supplementary Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Corporation Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck KGaA Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Alkem Laboratories
6.6.1 Alkem Laboratories Corporation Information
6.6.2 Alkem Laboratories Description and Business Overview
6.6.3 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.6.5 Alkem Laboratories Recent Developments/Updates
6.7 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Corporation Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharma Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Allergan
6.10.1 Allergan Corporation Information
6.10.2 Allergan Description and Business Overview
6.10.3 Allergan Over the Counter (OTC) & Diet Supplementary Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Allergan Over the Counter (OTC) & Diet Supplementary Product Portfolio
6.10.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Over the Counter (OTC) & Diet Supplementary Industry Chain Analysis
7.2 Over the Counter (OTC) & Diet Supplementary Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Over the Counter (OTC) & Diet Supplementary Production Mode & Process
7.4 Over the Counter (OTC) & Diet Supplementary Sales and Marketing
7.4.1 Over the Counter (OTC) & Diet Supplementary Sales Channels
7.4.2 Over the Counter (OTC) & Diet Supplementary Distributors
7.5 Over the Counter (OTC) & Diet Supplementary Customers
8 Over the Counter (OTC) & Diet Supplementary Market Dynamics
8.1 Over the Counter (OTC) & Diet Supplementary Industry Trends
8.2 Over the Counter (OTC) & Diet Supplementary Market Drivers
8.3 Over the Counter (OTC) & Diet Supplementary Market Challenges
8.4 Over the Counter (OTC) & Diet Supplementary Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Over the Counter (OTC) & Diet Supplementary Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Over the Counter (OTC) & Diet Supplementary Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Over the Counter (OTC) & Diet Supplementary Market Competitive Situation by Manufacturers in 2022
Table 4. Global Over the Counter (OTC) & Diet Supplementary Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Over the Counter (OTC) & Diet Supplementary Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Over the Counter (OTC) & Diet Supplementary Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Over the Counter (OTC) & Diet Supplementary Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Over the Counter (OTC) & Diet Supplementary, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Over the Counter (OTC) & Diet Supplementary, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Over the Counter (OTC) & Diet Supplementary, Product Type & Application
Table 12. Global Key Manufacturers of Over the Counter (OTC) & Diet Supplementary, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Over the Counter (OTC) & Diet Supplementary by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) & Diet Supplementary as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Over the Counter (OTC) & Diet Supplementary Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Over the Counter (OTC) & Diet Supplementary Sales by Region (2018-2023) & (K MT)
Table 18. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Region (2018-2023)
Table 19. Global Over the Counter (OTC) & Diet Supplementary Sales by Region (2024-2029) & (K MT)
Table 20. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Region (2024-2029)
Table 21. Global Over the Counter (OTC) & Diet Supplementary Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Region (2018-2023)
Table 23. Global Over the Counter (OTC) & Diet Supplementary Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Region (2024-2029)
Table 25. North America Over the Counter (OTC) & Diet Supplementary Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2023) & (K MT)
Table 27. North America Over the Counter (OTC) & Diet Supplementary Sales by Country (2024-2029) & (K MT)
Table 28. North America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Over the Counter (OTC) & Diet Supplementary Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2023) & (K MT)
Table 32. Europe Over the Counter (OTC) & Diet Supplementary Sales by Country (2024-2029) & (K MT)
Table 33. Europe Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Over the Counter (OTC) & Diet Supplementary Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Over the Counter (OTC) & Diet Supplementary Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Over the Counter (OTC) & Diet Supplementary Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Over the Counter (OTC) & Diet Supplementary Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Over the Counter (OTC) & Diet Supplementary Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Over the Counter (OTC) & Diet Supplementary Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Over the Counter (OTC) & Diet Supplementary Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Over the Counter (OTC) & Diet Supplementary Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Over the Counter (OTC) & Diet Supplementary Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Over the Counter (OTC) & Diet Supplementary Sales (K MT) by Type (2018-2023)
Table 51. Global Over the Counter (OTC) & Diet Supplementary Sales (K MT) by Type (2024-2029)
Table 52. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Type (2018-2023)
Table 53. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Type (2024-2029)
Table 54. Global Over the Counter (OTC) & Diet Supplementary Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Over the Counter (OTC) & Diet Supplementary Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Type (2018-2023)
Table 57. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Type (2024-2029)
Table 58. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Type (2018-2023)
Table 59. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Type (2024-2029)
Table 60. Global Over the Counter (OTC) & Diet Supplementary Sales (K MT) by Application (2018-2023)
Table 61. Global Over the Counter (OTC) & Diet Supplementary Sales (K MT) by Application (2024-2029)
Table 62. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Application (2018-2023)
Table 63. Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Application (2024-2029)
Table 64. Global Over the Counter (OTC) & Diet Supplementary Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Over the Counter (OTC) & Diet Supplementary Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Application (2018-2023)
Table 67. Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Application (2024-2029)
Table 68. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Application (2018-2023)
Table 69. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Application (2024-2029)
Table 70. Bayer AG Corporation Information
Table 71. Bayer AG Description and Business Overview
Table 72. Bayer AG Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Bayer AG Over the Counter (OTC) & Diet Supplementary Product
Table 74. Bayer AG Recent Developments/Updates
Table 75. Merck KGaA Corporation Information
Table 76. Merck KGaA Description and Business Overview
Table 77. Merck KGaA Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Merck KGaA Over the Counter (OTC) & Diet Supplementary Product
Table 79. Merck KGaA Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Novartis Over the Counter (OTC) & Diet Supplementary Product
Table 84. Novartis Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Alkem Laboratories Corporation Information
Table 96. Alkem Laboratories Description and Business Overview
Table 97. Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Product
Table 99. Alkem Laboratories Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Corporation Information
Table 101. Teva Pharmaceutical Industries Description and Business Overview
Table 102. Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Product
Table 104. Teva Pharmaceutical Industries Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Pfizer Over the Counter (OTC) & Diet Supplementary Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Sun Pharma Corporation Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Sun Pharma Over the Counter (OTC) & Diet Supplementary Product
Table 114. Sun Pharma Recent Developments/Updates
Table 115. Allergan Corporation Information
Table 116. Allergan Description and Business Overview
Table 117. Allergan Over the Counter (OTC) & Diet Supplementary Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Allergan Over the Counter (OTC) & Diet Supplementary Product
Table 119. Allergan Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Over the Counter (OTC) & Diet Supplementary Distributors List
Table 123. Over the Counter (OTC) & Diet Supplementary Customers List
Table 124. Over the Counter (OTC) & Diet Supplementary Market Trends
Table 125. Over the Counter (OTC) & Diet Supplementary Market Drivers
Table 126. Over the Counter (OTC) & Diet Supplementary Market Challenges
Table 127. Over the Counter (OTC) & Diet Supplementary Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Over the Counter (OTC) & Diet Supplementary
Figure 2. Global Over the Counter (OTC) & Diet Supplementary Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Over the Counter (OTC) & Diet Supplementary Market Share by Type in 2022 & 2029
Figure 4. Analgesic & Pain Relievers Product Picture
Figure 5. Dermatological Products Product Picture
Figure 6. Cough, Cold and Flu Products Product Picture
Figure 7. Vitamin Supplements Product Picture
Figure 8. Mineral Supplements Product Picture
Figure 9. Ophthalmic Products Product Picture
Figure 10. Global Over the Counter (OTC) & Diet Supplementary Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Over the Counter (OTC) & Diet Supplementary Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Global Over the Counter (OTC) & Diet Supplementary Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Over the Counter (OTC) & Diet Supplementary Market Size (2018-2029) & (US$ Million)
Figure 16. Global Over the Counter (OTC) & Diet Supplementary Sales (2018-2029) & (K MT)
Figure 17. Global Over the Counter (OTC) & Diet Supplementary Average Price (USD/MT) & (2018-2029)
Figure 18. Over the Counter (OTC) & Diet Supplementary Report Years Considered
Figure 19. Over the Counter (OTC) & Diet Supplementary Sales Share by Manufacturers in 2022
Figure 20. Global Over the Counter (OTC) & Diet Supplementary Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Over the Counter (OTC) & Diet Supplementary Players: Market Share by Revenue in 2022
Figure 22. Over the Counter (OTC) & Diet Supplementary Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Over the Counter (OTC) & Diet Supplementary Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Over the Counter (OTC) & Diet Supplementary Sales Market Share by Country (2018-2029)
Figure 25. North America Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Over the Counter (OTC) & Diet Supplementary Sales Market Share by Country (2018-2029)
Figure 29. Europe Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Country (2018-2029)
Figure 30. Germany Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Over the Counter (OTC) & Diet Supplementary Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Region (2018-2029)
Figure 37. China Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Taiwan Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Philippines Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Over the Counter (OTC) & Diet Supplementary Sales Market Share by Country (2018-2029)
Figure 48. Latin America Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. U.A.E Over the Counter (OTC) & Diet Supplementary Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Over the Counter (OTC) & Diet Supplementary by Type (2018-2029)
Figure 58. Global Revenue Market Share of Over the Counter (OTC) & Diet Supplementary by Type (2018-2029)
Figure 59. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Type (2018-2029)
Figure 60. Global Sales Market Share of Over the Counter (OTC) & Diet Supplementary by Application (2018-2029)
Figure 61. Global Revenue Market Share of Over the Counter (OTC) & Diet Supplementary by Application (2018-2029)
Figure 62. Global Over the Counter (OTC) & Diet Supplementary Price (USD/MT) by Application (2018-2029)
Figure 63. Over the Counter (OTC) & Diet Supplementary Value Chain
Figure 64. Over the Counter (OTC) & Diet Supplementary Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs